PhaseV
Healthcare AI
Clinical development / clinical trial optimization
Series A
PhaseV is a Boston-based AI/ML company focused on clinical development for biopharma sponsors and CROs. Its platform applies causal machine learning, generative AI, and real-world data to help users design, monitor, and optimize adaptive, Bayesian, and fixed clinical trials, analyze heterogeneous treatment effects, stratify patients, and improve trial planning and execution.
Company Details
- Website
- phasevtrials.com
- Headquarters
- Boston, MA, USA
- Funding
- $65M
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring